FDA Guidance On Substance Use Disorder Supports Medical Device Innovation
Executive Summary
In a 30 August guidance from the US FDA, the agency proposed support and guidance for medical device innovation to treat substance use disorder.
You may also be interested in...
FDA Seeks To Spur Innovation In Devices Designed To Treat Opioid Abuse
Draft guidance from the US Food and Drug Administration provides recommendations for the development of medical devices to treat opioid use disorder and considerations for sponsors of clinical studies to evaluate them.
FDA Committee To Hold Meeting On Genetic Test For Opioid Use Disorder
The FDA will discuss the de novo request for opioid use disorder genetic test, AvertD.
Opioid Approval Standards Could Change Under New US FDA Plan
The Overdose Prevention Framework includes considering whether FDA should require new opioids show superior safety compared to existing products.